Tirzepatide
A dual-action metabolic peptide for appetite and weight.

Available options
Free Omniva delivery on orders over €50.00.
Free Omniva delivery on larger orders. Pay and confirm on Telegram after you place the order.
What is it?
Tirzepatide works on two gut-hormone pathways at once, GIP and GLP-1, rather than GLP-1 alone. It is used for appetite and metabolic goals.
Why people choose it
- Acts on two pathways, GIP and GLP-1
- Used for appetite and weight goals
- Available as a vial or a pre-filled pen
- Dosed once a week
What is it used for?
- Appetite and weight goals
- Blood sugar support
- Metabolic health
- Body composition
How it works
Tirzepatide acts on two appetite-and-blood-sugar pathways instead of one.
Good to know
- Available as a 10mg vial and a 30mg pen.
- Same family as Semaglutide and Retatrutide.
- Dose is stepped up gradually so your body adjusts comfortably.
Dose calculator
Enter a few details to see an illustrative protocol for this peptide.
Vials/pens to cover the full cycle at this dose.
How a typical cycle is structured over time (for reference).
Start low and step the dose up every few weeks so your body adjusts comfortably. Reconstitute once, then draw more units as you climb.
No mixing needed. Dial the pen to the number of clicks shown, then press to inject. 1 click = 0.1 mg.
Dosage protocol
Mixing amounts, dose steps and syringe draw volumes for this peptide.
Mixing (reconstitution)
| Vial | Add BAC water | Concentration | 1 unit (0.01 ml) |
|---|---|---|---|
| 10 mg | 2.0 ml | 5.0 mg/mL | 50 mcg |
| 30 mg | 3.0 ml | 10.0 mg/mL | 100 mcg |
Dosing schedule
Vial: 10 mg
| Phase | Dose | Units | Volume |
|---|---|---|---|
| Weeks 1–4 | 2.5 mg | 50 units | 0.50 ml |
| Weeks 5–8 | 5 mg | 100 units | 1.00 ml |
| Weeks 9–12 | 7.5 mg | 75 units | 0.75 mlsplit into 2 injections at different sites |
| Weeks 13–16 | 10 mg | 100 units | 1.00 mlsplit into 2 injections at different sites |
Vial: 30 mg
| Phase | Dose | Units | Volume |
|---|---|---|---|
| Weeks 1–4 | 2.5 mg | 25 units | 0.25 ml |
| Weeks 5–8 | 5 mg | 50 units | 0.50 ml |
| Weeks 9–12 | 7.5 mg | 75 units | 0.75 ml |
| Weeks 13–16 | 10 mg | 100 units | 1.00 ml |
Storage
- Avoid freeze-thaw cycles
Technique
- Clean the vial stopper and the skin with an alcohol swab and let both air-dry.
- Pinch a skinfold and insert the needle at 45–90° into the subcutaneous tissue.
- Do not aspirate for subcutaneous injections. Inject slowly and steadily.
- Wait 5–10 seconds before withdrawing, then apply gentle pressure. Do not rub the site.
- Rotate sites between the abdomen (at least 5 cm from the navel), thighs and upper arms to avoid lipohypertrophy.
- Use a new sterile 28–31 G insulin syringe every time and dispose of it in a sharps container.
Related peptides

Semaglutide
A GLP-1 peptide used for appetite and weight goals.

Retatrutide
A multi-receptor metabolic peptide for appetite and weight.

NAD+
A cellular-energy molecule used for vitality and clarity.